Long-term hydrochlorothiazide use and risk of cutaneous neoplasms
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2021/01/01
-
Journal
-
Indian UGC (journal)
-
Refrences13
-
Citations3
-
HeberRew Bright
-
SujithJ Chandy
-
Renu George
-
Meera Thomas
-
Pradeep Rajkumar
-
Anju George
Cite
Bright, HeberRew, et al. “Long-Term Hydrochlorothiazide Use and Risk of Cutaneous Neoplasms”. Current Medical Issues, vol. 19, no. 4, 2021, p. 264, https://doi.org/10.4103/cmi.cmi_36_21.
Bright, H., Chandy, S., George, R., Thomas, M., Rajkumar, P., & George, A. (2021). Long-term hydrochlorothiazide use and risk of cutaneous neoplasms. Current Medical Issues, 19(4), 264. https://doi.org/10.4103/cmi.cmi_36_21
Bright H, Chandy S, George R, Thomas M, Rajkumar P, George A. Long-term hydrochlorothiazide use and risk of cutaneous neoplasms. Current Medical Issues. 2021;19(4):264.
Journal Category
Medicine
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea | The Korean Journal of Internal Medicine |
| 25 | 2020 |
Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study | British Journal of Cancer |
| 35 | 2019 |
Hydrochlorothiazide use is strongly associated with risk of lip cancer | Journal of Internal Medicine |
| 108 | 2017 |
| , Wolfe CM, Heinrichs E.Hydrochlorothiazide use and skin cancer: A mohs surgeon's concern | Dermatologic Surgery |
| 2016 | |
| Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites | Journal of the American College of Cardiology |
| 34 | 2015 |
Refrences Analysis
The category
Medicine: Medicine (General) 11
is the most frequently represented among the references in this article. It primarily includes studies from British Journal of Cancer The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Anti-hypertensive medications and risk of melanoma and keratinocyte carcinomas: a systematic review and meta-analysis | JID Innovations | 2024 | ||
Commentary on: “Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study | Acta Dermato-Venereologica |
| 2023 | |
| Commentary on: “Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study | Acta Dermato-Venereologica |
| 2023 |
Citations Analysis
| Category | Category Repetition |
|---|---|
| Medicine: Dermatology | 2 |
| Medicine | 2 |
| Medicine: Medicine (General) | 2 |
The category
Medicine: Dermatology 2
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Commentary on: “Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study and was published in 2023. The most recent citation comes from a 2024 study titled Anti-hypertensive medications and risk of melanoma and keratinocyte carcinomas: a systematic review and meta-analysis. This article reached its peak citation in 2023, with 2 citations. It has been cited in 2 different journals, 50% of which are open access. Among related journals, the Acta Dermato-Venereologica cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.